Clinical Trial Update: Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

Tioga Pharmaceuticals' Phase 2 trial of asimadoline for irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Asimadoline (asimadoline)

Snippet

Sponsor: Tioga Pharmaceuticals | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED